Adia Nutrition, Inc.

Adia Nutrition, Inc. has fully repaid and discharged its unsecured revolving line of credit facility, originally entered into on June 30, 2024, with its Chief Executive Officer, Larry Powalisz, as the lender. The facility, which had a commitment of $1,000,000 and an interest rate of 6% per annum, was settled through payments totaling $934,970.94, including accrued interest. The lender has acknowledged the full satisfaction of all outstanding principal and interest as of October 9, 2026.

Adia Nutrition reported a significant increase in revenue for the second quarter of 2026, reaching $485,385, up 310.8% year-over-year, and achieved a net income of $40,418 compared to a loss in the prior year. For the six months ended June 30, 2026, revenue grew to $661,660, and the net loss was reduced. Despite these improvements, the company has an accumulated deficit of over $16 million and management expressed substantial doubt about its ability to continue as a going concern.

Adia Nutrition reported a significant increase in total revenue to $176,275 for Q1 2026, up from $71,764 in Q1 2025, driven by medical procedures and new sales of biologics. Despite this revenue growth and a higher gross profit of $67,577, the company's net loss widened to $162,525, compared to a $116,219 net loss in the prior year, primarily due to increased operating expenses. The company continues to operate with a going concern warning due to its accumulated deficit of $16.1 million.